Derma Sciences Inc  

(Public, NASDAQ:DSCI)   Watch this stock  
Find more results for DSCI
8.69
-0.22 (-2.47%)
Jan 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 8.65 - 9.00
52 week 7.88 - 15.51
Open 8.84
Vol / Avg. 55,972.00/97,979.00
Mkt cap 223.42M
P/E     -
Div/yield     -
EPS -1.52
Shares 25.25M
Beta 0.88
Inst. own 88%
Dec 11, 2014
Derma Sciences, Inc. at Oppenheimer Healthcare Conference
Dec 3, 2014
Derma Sciences, Inc. at Piper Jaffray Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -55.77% -30.06%
Operating margin -55.02% -30.10%
EBITD margin - -25.43%
Return on average assets -29.72% -24.91%
Return on average equity -32.30% -28.05%
Employees 258 -
CDP Score - -

Address

SUITE 300 214 CARNEGIE CENTER
PRINCETON, NJ 08540
United States - Map
+1-609-5144744 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Derma Sciences, Inc. (Derma Sciences) is a tissue regeneration company. The Company is focused on three segments of the wound care marketplace: advanced wound care, which provides Medihoney dressings, Bioguard, Xtrasorb, TCC-EZ, ALGICELL AG and DERMAGRAN products; traditional wound care, which offers branded gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices for the medical markets; and pharmaceutical wound care, which offers DSC127, an angiotensin analog. The Company markets its products principally through direct sales representatives in the United States, Canada and the United Kingdom, and through independent distributors within other international markets. The Company�s U.S. distribution facilities are located in St. Louis, Missouri and Houston, Texas. The Company has manufacturing facilities in Toronto, Canada and Nantong, China.

Officers and directors

Edward J. Quilty Chairman of the Board, President, Chief Executive Officer
Age: 63
Bio & Compensation  - Reuters
John E. Yetter CPA Chief Financial Officer, Executive Vice President - Finance
Age: 61
Bio & Compensation  - Reuters
Robert C. Cole Group President - Traditional Wound Care and Corporate Accounts
Age: 61
Bio & Compensation  - Reuters
Barry J. Wolfenson Group President - Advanced Wound Care and Pharmaceutical Development
Age: 47
Bio & Compensation  - Reuters
Frederic Eigner Executive Vice President - Operations; General Manager of Derma Sciences Canada, Inc.
Age: 64
Bio & Compensation  - Reuters
Bruce F. Wesson Vice Independent Lead Director
Age: 71
Bio & Compensation  - Reuters
Stephen T. Wills CPA Lead Independent Director
Age: 57
Bio & Compensation  - Reuters
Srini Conjeevaram Independent Director
Age: 55
Bio & Compensation  - Reuters
Brett D. Hewlett Independent Director
Age: 51
Bio & Compensation  - Reuters
Robert G. Moussa Independent Director
Age: 67
Bio & Compensation  - Reuters